Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephen R. Goding
17-Aag Inhibits Vemurafenib-Associated MAP Kinase Activation and Is Synergistic With Cellular Immunotherapy in a Murine Melanoma Model
PLoS ONE
Multidisciplinary
Related publications
Synergistic Effects of Vemurafenib and Fingolimod (FTY720) in Vemurafenib‑resistant Melanoma Cell Lines
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Effects of Macrofungal Polysaccharides Combined With Vemurafenib on Melanoma and Its Associated Mechanism
International Journal of Polymer Science
Polymers
Plastics
Angiostatin Inhibits Endothelial and Melanoma Cellular Invasion by Blocking Matrix-Enhanced Plasminogen Activation
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Rheb Is in a High Activation State and Inhibits B-Raf Kinase in Mammalian Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Systematic Review and Meta-Analysis of Prevalence of Dermatological Toxicities Associated With Vemurafenib Treatment in Patients With Melanoma
Clinical and Experimental Dermatology
Dermatology
Metastatic Melanoma and Vemurafenib: Novel Approaches
Rare Tumors
Oncology
Histology
Trypanosoma Cruzi: Phosphatidylinositol 3-Kinase and Protein Kinase B Activation Is Associated With Parasite Invasion
Experimental Cell Research
Cell Biology
Combination of Rapamycin, CI-1040, and 17-Aag Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
PLoS ONE
Multidisciplinary
